+91 8744044044 / 8750295029
info@globalpharmanetwork.com
Global Pharma Network

Daratumumab

Daratumumab was given breakthrough therapy drug status in 2013 for multiple myeloma. It was awarded orphan drug status for multiple myeloma, diffuse large B cell lymphoma, follicular lymphoma, and mantle cell lymphoma.

Generic Version of Daratumumab Medicine

Query Form

Please fill in the details about your
medicine requirement on this form.

Global Pharma Network

60/4, T&T House. Yusuf Sarai.
New Delhi:110016 India.

Phone number

+91 8744044044

Email

info@globalpharmanetwork.com

Daratumumab is approved to treat multiple myeloma, diffuse large B cell lymphoma, follicular lymphoma, and mantle cell lymphoma..

Daratumumab (trade name Darzalex) is an anti-cancer drug. It binds to CD38, which multiple myeloma cells overexpress. In November 2015, the U.S. Food and Drug Administration (FDA) approved daratumumab for treatment of multiple myeloma in patients who had received at least three prior therapies. In May 2016 daratumumab was also conditionally approved by the European Medicines Agency for treatment of multiple myeloma. In November 2016, the FDA approved daratumumab in combination with lenalidomide or bortezomib and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy. In May 2018, the FDA expanded the approval of daratumumab for use in combination with bortezomib, melphalan and prednisone to include the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant.

Daratumumab Price, Multiple Myeloma Treatment, Generic Daratumumab sold under the brand name in India
Daratumumab is used to treat Multiple Myeloma.

Details of Daratumumab Medication

Daratumumab

Global Pharma Network can help you to provide access of Daratumumab medications sold under the brand name for Multiple Myeloma treatment by connecting Patients, Health Care Centers, Pharmacies and Retail Outlets with approved supplier, exporter and distributor of Generic drugs, innovator brands and biosimilar medicines from India. Call Mr. Tarun at +91 8744044044 for more details.

For Urgent Requirement "Daratumumab" Medication

Call at +91 9891296838 / 9811747774 for Daratumumab availability, Daratumumab Price and Daratumumab sold under the brand name. How to procure FDA approved Daratumumab Drugs for treatment of Multiple Myeloma in India and overseas?

Global Pharma
Network

A Certified Pharmaceutical Wholesaler, Supplier, Exporters from India of FDA approved Daratumumab a targeted therapy drug sold under the brand name for treatment of Multiple Myeloma in India and overseas. We will help you in importing and exporting this medicine only upon the valid prescription of a licensed medical practitioner and other documents as required by the laws of the jurisdiction in which you are present. USA, UK, Russia, China, India, Nepal, Bhutan, Myanmar / Burma, Laos, Thailand, Cambodia, Hong Kong, Macau, Malaysia, Indonesia, Middle East, Japan, Philippines.

Disclaimer

The information on the website is obtained through many different sources and the accuracy should be confirmed prior to use. The content of this website is not intended to be instructional for medical diagnosis or treatment. Always consult with your physician or qualified health care provider on medical issues.